Cited by 279Hormonal Regulation and HypertensionObstructive Sleep Apnea ResearchBlood Pressure and Hypertension Studies

The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.

Resistant Hypertension, Obesity, Sleep Apnea, and Aldosterone: Theory and Therapy

Goodfriend, Theodore L., Calhoun, David A.·2004·Hypertension

Open this paper in CoChat — free account

Abstract

Hypertension resistant to 2 antihypertensive drugs is more common among obese patients than among lean patients. The case we describe and the observations we report suggest that refractoriness among obese hypertensives is frequently caused by obstructive sleep apnea and/or inappropriately high plasma aldosterone levels. In other words, obese hypertensives may have sleep apnea, obese hypertensives without sleep apnea may have inappropriately elevated levels of plasma aldosterone, and a surprising number of obese patients with sleep apnea also have elevated levels of aldosterone. The mechanisms by which obesity and obstructive sleep apnea increase aldosterone levels and raise blood pressure are not understood, but sympathetic nervous system activation and production of nonclassical adrenal stimuli are two possibilities. Obstructive sleep apnea can be detected with a careful history and various sleep studies. Inappropriately elevated aldosterone levels can be detected by measuring the ratio of plasma aldosterone concentration to plasma renin activity. Successful treatment of these resistant hypertensives often can be achieved by devices that provide positive pressure to the upper airway to correct obstructive sleep apnea and by incorporating an aldosterone antagonist in the therapeutic regimen.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1161/01.hyp.0000116223.97436.e5

Cites

61 of 61 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
Pitt, B., Zannad, F., Remme, W. J., Cody, R., Castaigne, A., Perez, A., Palensky, J., & Wittes, J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909023411001 · Cited by 9,214
Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.23.2981 · Cited by 5,664
Cardiovascular morbidity and mortality in the losartan intervention for endpoint reduction in hypertension study (LIFE): A randomised trial against atenolol
Dahlöf, B., Devereux, R. B., Kjeldsen, S. E., Julius, S., Beevers, G., de Faire, U., Fyhrquist, F., Ibsen, H., Kristiansson, K., Lederballe-Pedersen, O., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08089-3 · Cited by 5,407
Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction
Pitt, B., Remme, W., Zannad, F., Neaton, J., Martinez, F., Roniker, B., Bittman, R., Hurley, S., Kleiman, J., & Gatlin, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030207 · Cited by 4,941
Insulin Resistance in Essential Hypertension
Ferrannini, E., Buzzigoli, G., Bonadonna, R., Giorico, M. A., Oleggini, M., Graziadei, L., Pedrinelli, R., Brandi, L., & Bevilacqua, S. (1987) · New England Journal of Medicine · doi:10.1056/nejm198708063170605 · Cited by 2,344
Hypertension and associated metabolic abnormalities–the role of insulin resistance and the sympathoadrenal system.
Reaven, G. M., Lithell, H., & Landsberg, L. (1996) · New England Journal of Medicine · doi:10.1056/nejm199602083340607 · Cited by 1,435
Obesity and Systemic Oxidative Stress: Clinical Correlates of Oxidative Stress in The Framingham Study
Keaney, J. F., Larson, M. G., Vasan, R. S., Wilson, P. W. F., Lipinska, I., Corey, D., Massaro, J. M., Sutherland, P., Vita, J. A., & Benjamin, E. J. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000058402.34138.11 · Cited by 1,304
Regional adiposity and morbidity.
Kissebah, A. H., & Krakower, G. R. (1994) · Physiological Reviews · doi:10.1152/physrev.1994.74.4.761 · Cited by 1,132
Original Papers. Success and Predictors of Blood Pressure Control in Diverse North American Settings: The Antihypertensive and Lipid‐Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
Cushman, W. C., Ford, C. E., Cutler, J. A., Margolis, K. L., Davis, B. R., Grimm, R. H., Black, H. R., Hamilton, B. P., Holland, J., Nwachuku, C., et al. (2002) · The Journal of Clinical Hypertension · doi:10.1111/j.1524-6175.2002.02045.x · Cited by 979
Population-Based Study of Sleep-Disordered Breathing as a Risk Factor for Hypertension
Young, T. B. (1997) · Archives of Internal Medicine · doi:10.1001/archinte.1997.00440360178019 · Cited by 967

Show all 61 references

Research works printed but not linked: 7

10.1161/hyp.31.1.64 · DOI
10.1161/circ.96.10.3423 · DOI
10.1161/hyp.30.3.619 · DOI
10.1161/circ.98.8.772 · DOI
10.1161/circ.100.23.2332 · DOI
10.1161/hyp.34.2.309 · DOI
Scavo D, Borgia C, Iacobelli A. Aspetti di funzione corticosurrenalica nell obesita. Folia Endocrinol. 1968; 21: 307–310.

Sorted by citations

Items 101–200 of 276

Drug-resistant hypertension in primary aldosteronism patients undergoing adrenal vein sampling: the AVIS-2-RH study
Rossi, G. P., Rossitto, G., Amar, L., Azizi, M., Riester, A., Reincke, M., Degenhart, C., Widimsky, J., Jr., Naruse, M., Deinum, J., et al. (2021) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwaa108 · Cited by 38
Fat tissue metabolism and adrenal steroid secretion
Lamounier-Zepter, V., & Ehrhart-Bornstein, M. (2006) · Current Hypertension Reports · doi:10.1007/s11906-006-0038-3 · Cited by 34
Avanços recentes do impacto da apneia obstrutiva do sono na hipertensão arterial sistêmica
Pedrosa, R. P., Krieger, E. M., Lorenzi‐Filho, G., & Drager, L. F. (2011) · Arquivos Brasileiros de Cardiologia · doi:10.1590/s0066-782x2011005000017 · Cited by 37
Resistant Hypertension: Diagnosis and Management
Papadopoulos, D. P., & Papademetriou, V. (2006) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248406289735 · Cited by 34
Aldosterone Inhibition and Cardiovascular Protection: More Important Than it Once Appeared
Martínez, F. A. (2010) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-010-6256-6 · Cited by 34
Neuroendocrine changes in sleep apnea
Yee, B. J., Liu, P. X., Phillips, C. L., & Grunstein, R. R. (2004) · Current Opinion in Pulmonary Medicine · doi:10.1097/01.mcp.0000143967.34079.27 · Cited by 33
Management of Hypertension in Obstructive Sleep Apnea
Furlan, S. F., Braz, C. V., Lorenzi‐Filho, G., & Drager, L. F. (2015) · Current Cardiology Reports · doi:10.1007/s11886-015-0663-z · Cited by 33
Mineralocorticoid Receptor Blockade in Chronic Kidney Disease
Volk, M. J., Bomback, A. S., & Klemmer, P. J. (2011) · Current Hypertension Reports · doi:10.1007/s11906-011-0202-2 · Cited by 33
FDA's stamp of approval: Unveiling peptide breakthroughs in cardiovascular diseases, ACE, HIV, CNS, and beyond
Musaimi, O. A. (2024) · Journal of Peptide Science · doi:10.1002/psc.3627 · Cited by 31
The Impact of Continuous Positive Airway Pressure on Blood Pressure in Patients with Obstructive Sleep Apnea Syndrome: Evidence From a Meta-analysis of Placebo-Controlled Randomized Trials
Elliott, W. J. (2008) · Yearbook of Cardiology · doi:10.1016/s0145-4145(08)05008-9 · Cited by 31
Secondary Hypertension: Obesity and the Metabolic Syndrome
Singer, G. M., & Setaro, J. F. (2008) · Journal of Clinical Hypertension · doi:10.1111/j.1751-7176.2008.08178.x · Cited by 31
Managing resistant hypertension: focus on mineralocorticoid-receptor antagonists
Yugar‐Toledo, J. C., Modolo, R., de Faria, A. P., & Moreno, H. (2017) · Vascular Health and Risk Management · doi:10.2147/vhrm.s138599 · Cited by 32
Treatment of resistant hypertension
Taler, S. J. (2005) · Current Hypertension Reports · doi:10.1007/s11906-005-0064-6 · Cited by 31
Combination therapy versus monotherapy as initial treatment for stage 2 hypertension: A prespecified subgroup analysis of a community-based, randomized, open-label trial
Everett, B. M., Glynn, R. J., Danielson, E., & Ridker, P. M. (2008) · Clinical Therapeutics · doi:10.1016/j.clinthera.2008.04.013 · Cited by 30
Effects of continuous positive airway pressure treatment on aldosterone excretion in patients with obstructive sleep apnoea and resistant hypertension
de Souza, F., Muxfeldt, E. S., Margallo, V. S., Cortez, A. F., Cavalcanti, A. H., & Salles, G. F. (2017) · Journal of Hypertension · doi:10.1097/hjh.0000000000001254 · Cited by 30
The Impact of Continuous Positive Airway Pressure on Blood Pressure in Patients with Obstructive Sleep Apnea Syndrome: Evidence From a Meta-analysis of Placebo-Controlled Randomized Trials
Elliott, W. J. (2008) · Yearbook of Medicine · doi:10.1016/s0084-3873(08)79244-7 · Cited by 29
Aldosterone—A Hormone of Cardiovascular Adaptation and Maladaptation
Goodfriend, T. L. (2006) · Journal of Clinical Hypertension · doi:10.1111/j.1524-6175.2006.05110.x · Cited by 28
Self-citation
Mineralocorticoid Receptor Blockade in Chronic Kidney Disease
Bomback, A. S., & Klemmer, P. J. (2012) · Blood Purification · doi:10.1159/000334161 · Cited by 28
Resistant Hypertension and Obstructive Sleep Apnea: The Sparring Partners
Thomopoulos, C., Michalopoulou, H., Kasiakogias, A., Kefala, A., & Makris, T. K. (2011) · International Journal of Hypertension · doi:10.4061/2011/947246 · Cited by 28
Does CPAP treatment in mild obstructive sleep apnea affect blood pressure?
Jaimchariyatam, N., Rodriguez, C. L., & Budur, K. S. (2010) · Sleep Medicine · doi:10.1016/j.sleep.2010.05.005 · Cited by 27
Oxidative Stress, Vascular Remodeling, and Vascular Inflammation in Hypertension
Renna, N. F. (2013) · International Journal of Hypertension · doi:10.1155/2013/710136 · Cited by 26
The metabolic syndrome in primary aldosteronism
Fallo, F., Federspil, G., Veglio, F., & Mulatero, P. (2008) · Current Diabetes Reports · doi:10.1007/s11892-008-0009-y · Cited by 28
Secondary Causes of Hypertension
Taler, S. J. (2008) · Primary Care Clinics in Office Practice · doi:10.1016/j.pop.2008.06.001 · Cited by 28
Sleep apnoea and cancer: current insights and future perspectives
Martínez‐García, M. Á., Campos‐Rodríguez, F., & Farré, R. (2012) · European Respiratory Journal · doi:10.1183/09031936.00127912 · Cited by 26
ANKRD36 Is Involved in Hypertension by Altering Expression of ENaC Genes
Yan, Y., Wang, J., Yu, L., Cui, B., Wang, H., Xiao, X., Zhang, Y., Zheng, J., Wang, J., Hui, R., et al. (2021) · Circulation Research · doi:10.1161/circresaha.121.319883 · Cited by 24
Primary aldosteronism and obstructive sleep apnea: What do we know thus far?
Loh, H. H., & Sukor, N. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.976979 · Cited by 23
A controlled clinical trial of the effect of gastric bypass surgery and intensive lifestyle intervention on nocturnal hypertension and the circadian blood pressure rhythm in patients with morbid obesity
Nordstrand, N., Hertel, J. K., Hofsø, D., Sandbu, R., Saltvedt, E., Røislien, J., Os, I., & Hjelmesaeth, J. S. (2012) · Surgery · doi:10.1016/j.surg.2011.12.007 · Cited by 23
The metabolic syndrome in primary aldosteronism
Fallo, F., Federspil, G., Veglio, F., & Mulatero, P. (2007) · Current Hypertension Reports · doi:10.1007/s11906-007-0019-1 · Cited by 23
Cardiovascular Risks and Organ Damage in Secondary Hypertension
Cingolani, O. H. (2019) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2019.08.015 · Cited by 22
A review of the association between oral bacterial flora and obstructive sleep apnea–hypopnea syndrome comorbid with cardiovascular disease
Zeng, Y., Hu, A., Su, H., & Ko, C. (2019) · Sleep And Breathing · doi:10.1007/s11325-019-01962-9 · Cited by 21
Is Surgery the Next Answer to Treat Obesity‐Related Hypertension?
Frezza, E. E., Cai, W., & Wachtel, M. S. (2009) · Journal of Clinical Hypertension · doi:10.1111/j.1751-7176.2009.00123.x · Cited by 21
Beneficial long-term effect of aldosterone antagonist added to a traditional blockade of the renin–angiotensin–aldosterone system among patients with obesity and proteinuria
Morales, E., Gutiérrez, E., Caro, J., Sevillano, Á., Rojas-Rivera, J. E., & Praga, M. (2015) · Nefrología · doi:10.1016/j.nefro.2015.09.008 · Cited by 20
Resistant Hypertension: Diagnosis and Management
Nagarajan, N., & Jalal, D. I. (2019) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2019.03.002 · Cited by 21
Hypertension: Issues in control and resistance
Wofford, M. R., & Minor, D. S. (2009) · Current Hypertension Reports · doi:10.1007/s11906-009-0055-0 · Cited by 20
Mecanismos e tratamento da hipertensão arterial refratária
Pimenta, E., Calhoun, D. A., & Oparil, S. (2007) · Arquivos Brasileiros de Cardiologia · doi:10.1590/s0066-782x2007000600009 · Cited by 19
Self-citation
Drug Mechanisms to Help in Managing Resistant Hypertension in Obesity
Jansen, P. M., Danser, J., Spiering, W., & van den Meiracker, A. H. (2010) · Current Hypertension Reports · doi:10.1007/s11906-010-0123-5 · Cited by 17
Pathophysiology of Obesity—Induced Hypertension and Target Organ Damage
Hall, J. E., da Silva, A. A., Brandon, E. L., Stec, D. E., Ying, Z., & Jones, D. W. (2007) · Elsevier eBooks · doi:10.1016/b978-0-323-03961-1.50041-6 · Cited by 18
Regulation of alternative splicing in obesity-induced hypertension
Dlamini, Z., Hull, R., Makhafola, T. J., & Mbele, M. (2019) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s188680 · Cited by 18
Cardiovascular Disease in Obstructive Sleep Apnea: Putative Contributions of Mineralocorticoid Receptors
Badran, M., Bender, S. B., & Gozal, D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032245 · Cited by 18
Treatment of Hypertension in Obese Patients
Kidambi, S., & Kotchen, T. A. (2013) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-013-0008-5 · Cited by 16
Who should be screened for primary aldosteronism? A comprehensive review of current evidence
Huang, W., Lin, Y., Wu, V., Chen, C., Siddique, S., Chia, Y. C., Tay, J. C., Guruprasad, S., Cheng, H., & Kario, K. (2022) · Journal of Clinical Hypertension · doi:10.1111/jch.14558 · Cited by 16
The Perioperative Implications of Obstructive Sleep Apnea
Paje, D. T. T., & Kremer, M. (2006) · Orthopaedic Nursing · doi:10.1097/00006416-200609000-00003 · Cited by 16
Why Is Blood Pressure So Hard to Control in Patients With Type 2 Diabetes?
Kazuo Eguchi MD, P., Pickering, T. G., & Kario, K. (2007) · Journal of the CardioMetabolic Syndrome · doi:10.1111/j.1559-4564.2007.06124.x · Cited by 16
High fat diet confers vascular hyper-contractility against angiotensin II through upregulation of MLCK and CPI-17
Kim, J. I. (2017) · Korean Journal of Physiology and Pharmacology · doi:10.4196/kjpp.2017.21.1.99 · Cited by 16
Secondary Hypertension, Issues in Diagnosis and Treatment
Pullalarevu, R., Akbar, G., & Teehan, G. S. (2014) · Primary Care Clinics in Office Practice · doi:10.1016/j.pop.2014.08.001 · Cited by 15
Treatment of hypertension in individuals with the cardiometabolic syndrome: role of an angiotensin II receptor blocker, telmisartan
Francischetti, E. A., Celoria, B. M. J., Francischetti, A., & Genelhu, V. A. (2008) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.6.3.289 · Cited by 15
Well Tolerated Spironolactone‐Related Hyponatremia
Handler, J. (2008) · Journal of Clinical Hypertension · doi:10.1111/j.1751-7176.2008.08063.x · Cited by 15
Effect of Spironolactone on Blood Pressure in Subjects With Resistant Hypertension
Elliott, W. J. (2008) · Yearbook of Cardiology · doi:10.1016/s0145-4145(08)05017-x · Cited by 15
Treating Resistant Hypertension With a Neglected Old Drug
Goodfriend, T. L. (2007) · Hypertension · doi:10.1161/01.hyp.0000259806.91169.01 · Cited by 15
Self-citation
Role of RAAS and adipokines in cardiovascular protection: effect of different doses of angiotensin II receptor blocker on adipokines level in hypertensive patients
Hass, A., Oz, H., Mashavi, M., & Shargorodsky, M. (2014) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2014.07.033 · Cited by 14
Chronic Intrarenal Insulin Replacement Reverses Diabetes Mellitus–Induced Natriuresis and Diuresis
Manhiani, M. M., Duggan, A. D., Wilson, H., & Brands, M. W. (2012) · Hypertension · doi:10.1161/hypertensionaha.111.185215 · Cited by 14
Interações entre síndrome da apnéia obstrutiva do sono e resistência à insulina
Carneiro, G., Filho, F. F. R., Togeiro, S. M., Tufik, S., & Zanella, M. T. (2007) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302007000700003 · Cited by 14
Agonistic AT1 Receptor Autoantibody Increases in Serum of Patients with Refractory Hypertension and Improves Ca2+ Mobilization in Cultured Rat Vascular Smooth Muscle Cells
Zhu, F., Sun, Y., Liao, Y.-H., Wei, Y.-M., Chen, M., Wang, M., & Zhou, Z. (2008) · Cellular and Molecular Immunology · doi:10.1038/cmi.2008.26 · Cited by 13
Resistant hypertension: Renal denervation or intensified medical treatment?
Morganti, A., & Mancia, G. (2017) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2017.12.010 · Cited by 13
Nocturia and obstructive sleep apnoea
Vrooman, O. P. J., Kerrebroeck, P. V., van Balken, M. R., van Koeveringe, G. A., & Rahnama’i, M. S. (2024) · Nature Reviews Urology · doi:10.1038/s41585-024-00887-7 · Cited by 13
Epidemiologie und Ätiologie der therapieresistenten Hypertonie
Schirpenbach, C., & Reincke, M. (2008) · Der Internist · doi:10.1007/s00108-008-2194-9 · Cited by 12
Aldosterone to Active Renin Ratio Is Associated With Nocturnal Blood Pressure in Obese and Treated Hypertensive Patients: The Styrian Hypertension Study
Grübler, M. R., Kienreich, K., Gaksch, M., Verheyen, N., Fahrleitner‐Pammer, A., Schmid, J., Grogorenz, J., Ablasser, K., Pieske, B. M., Tomaschitz, A., et al. (2014) · Journal of Clinical Hypertension · doi:10.1111/jch.12274 · Cited by 11
The Carotid Body a Common Denominator for Cardiovascular and Metabolic Dysfunction?
Badoer, E. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.01069 · Cited by 11
Primary Aldosteronism: a Continuum from Normotension to Hypertension
Wannachalee, T., & Turcu, A. F. (2021) · Current Cardiology Reports · doi:10.1007/s11886-021-01538-8 · Cited by 11
Changes in Plasma Angiotensin II and Circadian Rhythm of Blood Pressure in Hypertensive Patients with Sleep Apnea Syndrome Before and After Treatment
Wang, H.-L., Wang, Y., Zhang, Y., Chen, Y., Wang, X., Liu, Z.-X., Guo-li, J., Tong, H., Tian, Y., & Liu, Q.-Z. (2011) · Chinese Medical Sciences Journal · doi:10.1016/s1001-9294(11)60013-8 · Cited by 11
Difficult-to-Treat or Resistant Hypertension: Etiology, Pathophysiology, and Innovative Therapies
Papademetriou, V., Tsioufis, C. P., Gradman, A. H., & Punzi, H. A. (2011) · International Journal of Hypertension · doi:10.4061/2011/438198 · Cited by 11
Roux-en-Y gastric bypass attenuates the progression of cardiometabolic complications in obese diabetic rats via alteration in gastrointestinal hormones
Lau, R. G., Kumar, S., Hall, C. E., Palaia, T. A., Rideout, D. A., Hall, K. N., BRATHWAITE, C. E. M., & Ragolia, L. (2015) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2014.12.005 · Cited by 10
Update on diagnosis and treatment of resistant hypertension.
Pimenta, E. (2011) · Iranian Journal of Kidney Diseases · Cited by 10
Hypertonie und Ernährung
Dorner, T. E., Genser, D., Krejs, G. J., Slany, J., Watschinger, B., Ekmekçioğlu, C., & Rieder, A. (2012) · Herz · doi:10.1007/s00059-012-3613-1 · Cited by 10
Prevalence and severity of syndrome Z in women with metabolic syndrome on waiting list for bariatric surgery: a cross-sectional study
Perez, E. A., de Oliveira, L. V. F., de Freitas, W. R., Malheiros, C. A., Ilias, E. J., da Silva, A. S., Urbano, J. J., Oliveira, P. C., Cepeda, F. X., Sampaio, L. M. M., et al. (2017) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-017-0269-2 · Cited by 11
Prevalence and characteristics of resistant hypertension at primary clinics in Korea: a nationwide cross-sectional study
Lee, K., Na, J. O., Choi, C. U., Lim, H. E., Kim, J. W., Kim, E. J., Rha, S., Seo, H. S., Oh, D. J., & Park, C. G. (2015) · Clinical Hypertension · doi:10.1186/s40885-016-0043-z · Cited by 9
Renal Dysfunction in Hypertension and Obesity
Elmarakby, A. A., Pollock, D. M., & Imig, J. D. (2007) · Elsevier eBooks · doi:10.1016/b0-08-045044-x/00187-5 · Cited by 9
Reviving the use of aldosterone inhibitors in treating hypertension in obesity
Huby, A.-C., & de Chantemèle, E. J. B. (2015) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00133.2015 · Cited by 9
Efecto antiproteinúrico del bloqueo del sistema renina-angiotensina-aldosterona (SRAA) en los pacientes obesos: ¿Cuál es la opción terapéutica más eficaz?
Morales, E., Huerta, A., Gutiérrez, E., Solís, E. G., Segura, J., & Praga, M. (2009) · Hispana · Cited by 8
Challenges in obesity and primary aldosteronism: Diagnosis and treatment
Gershuni, V. M., Herman, D. S., Kelz, R. R., Roses, R. E., Cohen, D. L., Trerotola, S. O., Fraker, D. L., & Wachtel, H. (2019) · Surgery · doi:10.1016/j.surg.2019.03.036 · Cited by 8
Effects of Blood Pressure Lowering Agents on Cardiovascular Outcomes in Weight Excess Patients: A Systematic Review and Meta-analysis
Francischetti, E. A., de Abreu, V. G., Figueiredo, L. F. D. S., Dezonne, R. S., & Coutinho, E. S. F. (2020) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-019-00393-x · Cited by 8
Maximizing Diuretic Therapy in Resistant Hypertension
Handler, J. (2007) · Journal of Clinical Hypertension · doi:10.1111/j.1751-7176.2007.tb00009.x · Cited by 8
Apparent Treatment-Resistant Hypertension and Chronic Kidney Disease: Another Cardiovascular-Renal Syndrome?
Vemulapalli, S., Tyson, C. C., & Svetkey, L. P. (2014) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2014.08.006 · Cited by 8
Case Detection, Diagnosis, and Treatment of Patients with Primary Aldosteronism
(2013) · The Endocrine Society eBooks · doi:10.1210/ccpg.9781936704668.ch15 · Cited by 8
Renal Sinus Adiposity and Hypertension
Mazairac, A. H. A., & Joles, J. A. (2010) · Hypertension · doi:10.1161/hypertensionaha.110.158535 · Cited by 9
Prevalence, awareness, treatment, and control of hypertension in community-dwelling older adults with chronic kidney disease: the Irish longitudinal study on ageing
Browne, L., Alamin, M., Miri, H. H., Hall, R., Tandan, M., Sexton, D. J., & Stack, A. G. (2024) · Clinical Kidney Journal · doi:10.1093/ckj/sfae184 · Cited by 8
Increasing angiotensin-converting enzyme 1 regulated by histone 3 lysine 27 hyperacetylation in high-fat diet-induced hypertensive rat kidney
Lin, Y., Li, Y., Wang, H., Wu, H., Bai, B., Ma, L., Zou, J., Zhang, Q., & Shi, L. (2022) · Journal of Hypertension · doi:10.1097/hjh.0000000000003210 · Cited by 7
Obesity and hypertension
Simonyi, G., & Kollár, R. (2013) · Orvosi Hetilap · doi:10.1556/oh.2013.29738 · Cited by 7
Non-interventional management of resistant hypertension
Doumas, M. N. (2014) · World Journal of Cardiology · doi:10.4330/wjc.v6.i10.1080 · Cited by 7
Effects of continuous positive airway pressure therapy on hypertension control in patients with sleep-related breathing disorders: available evidence and unresolved issues
Marrone, O., Lombardi, C., & Parati, G. (2010) · Journal of Hypertension · doi:10.1097/hjh.0b013e32833f0e7e · Cited by 7
Obesity-Associated Hypertension
Uwaifo, G. I. (2012) · Humana Press eBooks · doi:10.1007/978-1-60761-548-4_13 · Cited by 7
Evaluation and treatment of resistant hypertension
Pimenta, E., & Calhoun, D. A. (2007) · Cited by 7
Self-citation
Pathophysiology of Hypertension
Franco, V., Calhoun, D. A., & Oparil, S. (2007) · Elsevier eBooks · doi:10.1016/b978-1-4160-3053-9.50009-3 · Cited by 7
Self-citation
Are Sleep Symptoms Predictors of Resistant Hypertension in a Population‐Based Sample? Findings From the National Health and Nutritional Examination Survey
Walia, H. K., Strohl, K. P., Koo, B. B., Seicean, A., & Seicean, S. (2012) · Journal of Clinical Hypertension · doi:10.1111/j.1751-7176.2012.00646.x · Cited by 6
Components of Metabolic Syndrome and Their Relation to Tinnitus
Gašpar, Ľ., Makovník, M., Bendžala, M., Hlinstáková, S., Očadlík, I., & Gasparov, E. (2011) · InTech eBooks · doi:10.5772/26980 · Cited by 6
Role of hypertension in the metabolic syndrome: Who is affected?
Velarde, G., & Berk, B. C. (2005) · Current Hypertension Reports · doi:10.1007/s11906-005-0036-x · Cited by 9
Efficacy of Spironolactone Therapy in Patients With True Resistant Hypertension
Elliott, W. J. (2011) · Yearbook of Cardiology · doi:10.1016/j.ycar.2011.01.107 · Cited by 6
Effect of Nocturnal Nasal Continuous Positive Airway Pressure on Blood Pressure in Obstructive Sleep Apnea
Elliott, W. J. (2008) · Yearbook of Cardiology · doi:10.1016/s0145-4145(08)05041-7 · Cited by 6
Primary aldosteronism: A consequence of sugar and western Diet?
Hahn, K. M., Rodríguez‐Iturbe, B., Winterberg, B., Sánchez‐Lozada, L. G., Kanbay, M., Lanaspa, M. A., & Johnson, R. J. (2022) · Medical Hypotheses · doi:10.1016/j.mehy.2022.110796 · Cited by 6
Phenylethanolamine N-methyltransferase gene expression in PC12 cells exposed to intermittent hypoxia
Khurana, S., Peng, S., McDonald, E., Yates, W., Venkataraman, K., & Tai, T. C. (2017) · Neuroscience Letters · doi:10.1016/j.neulet.2017.12.056 · Cited by 6
Resistant Hypertension
Hannah‐Shmouni, F., Gubbi, S., Spence, J. D., Stratakis, C. A., & Koch, C. A. (2019) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2019.08.010 · Cited by 6
Childhood Obesity and Blood Pressure Regulation
Rocchini, A. P. (2010) · Humana Press eBooks · doi:10.1007/978-1-60327-824-9_17 · Cited by 6
Prevalence and determinants of apparent treatment-resistant hypertension among patients in South African primary care: a single-centre observational study
Govender, K. C., & Naidoo, M. (2025) · BMC Cardiovascular Disorders · doi:10.1186/s12872-025-04813-6 · Cited by 5
Interaction of the C-344T polymorphism ofCYP11b2gene with body mass index and waist circumference affecting diastolic blood pressure in Chinese Mongolian population
Pan, X., Liu, Y., Zhang, Y., Zhang, X., Xu, Q., & Tong, W. (2010) · Blood Pressure · doi:10.3109/08037051.2010.495859 · Cited by 5
Current options for the treatment of resistant hypertension
Ahmed, M. I., Pisoni, R., & Calhoun, D. A. (2009) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.09.120 · Cited by 5
Self-citation
Should Patients with Obesity and Hypertension be Treated Differently from Those Who Are Not Obese?
Bloch, M. J., & Viera, A. J. (2014) · Current Hypertension Reports · doi:10.1007/s11906-014-0418-z · Cited by 5
Effects of continuous positive airway pressure therapy on plasma aldosterone levels in patients with obstructive sleep apnea: A meta-analysis
Deng, G., Qiu, Z., Li, D., Fang, Y., & Zhang, S. (2016) · Journal of Huazhong University of Science and Technology [Medical Sciences] · doi:10.1007/s11596-016-1636-1 · Cited by 5
Hipertensión arterial resistente
Feldstein, C. A. (2008) · Revista médica de Chile · doi:10.4067/s0034-98872008000400015 · Cited by 5
THE METABOLIC SYNDROME IN HYPERTENSION
Redon, J., Martinez, F., & Fabia, M. J. (2014) · CRC Press eBooks · doi:10.1201/b17072-46 · Cited by 5
Adiponectin as an Independent Predictor of Left Ventricular Hypertrophy in Nondiabetic Patients With Hypertension
Peer, M., Mashavi, M., Matas, Z., Harpaz, D., & Shargorodsky, M. (2014) · Angiology · doi:10.1177/0003319714523332 · Cited by 4

Authors: Goodfriend, T. L., & Calhoun, D. A.
Affiliations: University of Wisconsin–Madison (US)
ORCID: Calhoun, David A.
Venue: Hypertension
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2004-03
Volume: 43
Issue: 3
Pages: 518-524
ISSN: 0194-911X (ISSN-L)
1524-4563
DOI: 10.1161/01.hyp.0000116223.97436.e5
OpenAlex: W2114339665
Cited by: 279
References: 61
Citations by year: 2026: 2 · 2025: 4 · 2024: 4 · 2023: 1 · 2022: 9 · 2021: 3 · 2020: 7 · 2019: 12 · 2018: 11 · 2017: 11 · 2016: 6 · 2015: 14 · 2014: 27 · 2013: 11 · 2012: 21
FWCI: 10.32
Type: journal article
Language: en
Open access: closed
Locations: Hypertension (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
Health Sciences › Medicine › Physiology (medical) › Obstructive Sleep Apnea Research
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
Keywords: resistant hypertension, obesity, obstructive sleep apnea, plasma aldosterone, aldosterone-renin ratio, sympathetic activation, mineralocorticoid receptor antagonists, blood pressure regulation
MeSH terms: Aldosterone, Antihypertensive Agents, Drug Resistance, Humans, Hypertension, Male, Middle Aged, Models, Theoretical, Obesity, Sleep Apnea Syndromes

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Resistant Hypertension, Obesity, Sleep Apnea, and Aldosterone: Theory and Therapy

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks